| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/17/2008 | WO2008084861A1 Condensed pyridine compound |
| 07/17/2008 | WO2008084828A1 Method for producing coenzyme q10 particle |
| 07/17/2008 | WO2008084805A1 Composition for external use |
| 07/17/2008 | WO2008084762A1 Neurogenesis-promoting composition comprising theanine |
| 07/17/2008 | WO2008084717A1 Tricyclic compound and pharmaceutical use thereof |
| 07/17/2008 | WO2008084698A1 Tacrolimus sustained release pharmaceutical composition |
| 07/17/2008 | WO2008084676A1 Pharmaceutical composition comprising porous dry matrix |
| 07/17/2008 | WO2008084574A1 Anti-angiogenic agent |
| 07/17/2008 | WO2008084561A1 HELICOBACTER PYLORI GROWTH INHIBITOR CONTAINING α-N-ACETYLGLUCOSAMINYL-BINDING MONOSACCHARIDE DERIVATIVE |
| 07/17/2008 | WO2008084533A1 Therapeutic agent for meniere’s disease |
| 07/17/2008 | WO2008084504A2 Pharmaceutical compositions of angiotensin ii receptor blockers |
| 07/17/2008 | WO2008084496A1 Novel substituted 1h-benz [de] isoquinoline-1, 3 -diones |
| 07/17/2008 | WO2008084494A1 Novel polymorphic forms of carvedilol dihydrogen phosphate and process for preparing the same |
| 07/17/2008 | WO2008084492A1 5-(heterocyclyl)alkyl-n-(arylsulfonyl)indole compounds and their use as 5-ht6 ligands |
| 07/17/2008 | WO2008084491A1 4-(heterocyclyl)alkyl-n-(arylsulfonyl) indole compounds and their use as 5-ht6 ligands |
| 07/17/2008 | WO2008084484A1 Psychotropic compounds, compositions and methods of use |
| 07/17/2008 | WO2008084324A1 Naphthyridinone compound |
| 07/17/2008 | WO2008084319A2 Novel nucleic acid |
| 07/17/2008 | WO2008084312A2 Micronised particles of low-dosage strength active agents for powder formulations for inhalation |
| 07/17/2008 | WO2008084303A1 Compounds having both angiotensin ii receptor antagonism and ppary activating activities |
| 07/17/2008 | WO2008084300A1 Inhibitors of serine palmitoyltransferase |
| 07/17/2008 | WO2008084299A1 Succinate salt of 2-((4-(1-methyl-4-(pyridin-4-yl)-1h-pyrazol-3-yl) phenoxy)methyl)quinoline |
| 07/17/2008 | WO2008084268A1 Use of biglycan or enhancers of biglycan activity in the preparation of pharmaceutical compositions |
| 07/17/2008 | WO2008084261A1 Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors |
| 07/17/2008 | WO2008084253A1 Use of a galactolipid for wound and ulcer healing |
| 07/17/2008 | WO2008084241A2 Use of aminolevulinic acid and derivatives thereof |
| 07/17/2008 | WO2008084240A1 Chemical compounds 636 : pyridopyrimidinediones as pde4 inhibitors |
| 07/17/2008 | WO2008084236A1 Chemical compounds 635 : pyridopyrimidinediones as pde4 inhibitors |
| 07/17/2008 | WO2008084223A2 Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors |
| 07/17/2008 | WO2008084218A1 Benzazole derivatives for the treatment of inflammations |
| 07/17/2008 | WO2008084103A1 Combination treatment of solid cancers with antimetabolites and tyrosine kinase inhibitors |
| 07/17/2008 | WO2008084081A2 2-substituted 5-phenylpyrimidines for the treatment of proliferative disorders |
| 07/17/2008 | WO2008084062A1 New method for preparing unsaturated fatty hydroxy-acids |
| 07/17/2008 | WO2008084060A1 New method for preparing unsaturated fatty hydroxy-acids |
| 07/17/2008 | WO2008084057A1 Compounds with a combination of cannabinoid-cb1 antagonism and serotonin reuptake inhibition |
| 07/17/2008 | WO2008084051A1 Mixtures of pegylated insulin and fast acting insulin for pulmonary administration |
| 07/17/2008 | WO2008084044A1 Urea glucokinase activators |
| 07/17/2008 | WO2008084043A1 Urea glucokinase activators |
| 07/17/2008 | WO2008084005A1 Spiropiperidine glycinamide derivatives |
| 07/17/2008 | WO2008084004A1 Sulfonamide derivatives as chymase inhibitors |
| 07/17/2008 | WO2008083992A1 Use of gabab receptor selective agonists for treating inflammatory skin diseases |
| 07/17/2008 | WO2008083942A1 Use of sodium blockers for an early therapy of obstructive lung diseases |
| 07/17/2008 | WO2008083678A2 Pharmaceutically active compounds |
| 07/17/2008 | WO2008083634A1 1-(2-deoxy-alpha-d-erythro-pentofuranosyl)-5-azacytosine for use as drug |
| 07/17/2008 | WO2008083561A1 Oral pharmaceutical composition of glycyrrhizin or its salts and the preparation method thereof |
| 07/17/2008 | WO2008083551A1 4-substituted oxyphenyl quinolines, intermediate compounds, preparation methods and uses thereof |
| 07/17/2008 | WO2008083543A1 Nitrogen-containing heterocyclic modified compounds and uses thereof |
| 07/17/2008 | WO2008083508A1 Medically active plaster |
| 07/17/2008 | WO2008083491A1 Compounds and method for treatment of cancer |
| 07/17/2008 | WO2008083461A1 Plant compositions enriched in dehydrosoyasaponin i (d-i) and methods of producing such compositions |
| 07/17/2008 | WO2008083442A1 Method for formulating combination medications for adhd |
| 07/17/2008 | WO2008067450A3 6-alkoxyalkyl estradiol derivatives and methods of use |
| 07/17/2008 | WO2008067436A3 Compounds and formulations suitable for radical scavenging |
| 07/17/2008 | WO2008067219A3 Quinazolinone modulators of tgr5 |
| 07/17/2008 | WO2008065123A3 Polymorphic forms of deferasirox ( icl670a) |
| 07/17/2008 | WO2008065123A2 Polymorphic forms of deferasirox ( icl670a) |
| 07/17/2008 | WO2008065097A3 Stabilized solid pharmaceutical composition of candesartan cilexetil |
| 07/17/2008 | WO2008064815A3 Preparation for transdermally administering galanthamine |
| 07/17/2008 | WO2008063625A3 Pyridine compounds and methods of their use |
| 07/17/2008 | WO2008063300A3 Boronic acids and esters as inhibitors of fatty acid amide hydrolase |
| 07/17/2008 | WO2008062379A3 4- (2-oxo-oxazolidin-3yl)-phenoxymethyle derivativeas as antibacterials |
| 07/17/2008 | WO2008062379A2 4- (2-oxo-oxazolidin-3yl)-phenoxymethyle derivativeas as antibacterials |
| 07/17/2008 | WO2008061248A3 Phenylsulfoxyoxazole compound inhibitors of urea transporters |
| 07/17/2008 | WO2008060697A3 Dendron-tethered and templated quantum dots on carbon nanotubes |
| 07/17/2008 | WO2008059197A3 Topical composition comprising an anti- inflammatory steroid and a non-steroidal anti -inflammatory drug |
| 07/17/2008 | WO2008056257A3 Novel triazinedione derivatives as gaba-b receptor modulators |
| 07/17/2008 | WO2008055205A3 Pai-1 binding modulators for the treatment of ocular disorders |
| 07/17/2008 | WO2008051244A3 Anthranilic acid derivatives useful in treating infection with hepatitis c virus |
| 07/17/2008 | WO2008050101A3 Benzoyl amino heterocyclyl compounds useful in the treatment of a disease mediated through glk |
| 07/17/2008 | WO2008045564A8 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 07/17/2008 | WO2008043167A8 Pharmaceutical compositions comprising intra- and extra- granular fractions |
| 07/17/2008 | WO2008042867A3 Modulators of multiple kinases |
| 07/17/2008 | WO2008042282B1 Imidazole-4, 5-dicarboxamide derivatives as jak-2 modulators |
| 07/17/2008 | WO2008039492A3 Crystalline forms of valrubicin and processes for their preparation |
| 07/17/2008 | WO2008039482A3 Methods and compositions for cancer prevention and treatment |
| 07/17/2008 | WO2008037716A3 Pharmaceutical compositions comprising nilotinib or its salt |
| 07/17/2008 | WO2008037538A3 Modified alkoxyglycerols |
| 07/17/2008 | WO2008030584A3 Indazole derivatives as modulators of interleukin- 1 receptor-associated kinase |
| 07/17/2008 | WO2008029349A3 Muscarinic receptor antagonists |
| 07/17/2008 | WO2008028060A9 Anti-tumor compounds for inhibiting cancer growth |
| 07/17/2008 | WO2008027379A3 Indicators of sirtuin activity and methods of use thereof |
| 07/17/2008 | WO2008023278A3 1alpha-hydroxy-2- (3 ' -hydroxypropylidene) -19-n0r- vitamin d compounds with a 1,1-dimethylpropyl side chain |
| 07/17/2008 | WO2008021389A3 Using pi3k and mek modulators in treatments of cancer |
| 07/17/2008 | WO2008020405A3 Azetidine compounds as orexin receptor antagonists |
| 07/17/2008 | WO2008016547A9 Aurora kinase inhibitors from an encoded small molecule library |
| 07/17/2008 | WO2008002683A3 Polymorphous forms of carvedilol phosphate |
| 07/17/2008 | WO2007146039A3 Crystalline forms of n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl] thio]-2-thiazolyl]-4-piperidinecarboxamide |
| 07/17/2008 | WO2007145888A3 Oxime derivatives as inhibitors of macrophage migration inhibitory factor |
| 07/17/2008 | WO2007123868A3 Organic thiophosphate antiretroviral agents |
| 07/17/2008 | WO2007121312A9 Trivalent chromium compounds, compositions and methods of use |
| 07/17/2008 | WO2007121154A3 Substituted benzothiazole kinase inhibitors |
| 07/17/2008 | WO2007120688A3 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators |
| 07/17/2008 | WO2007115231A3 Cxcr4 modulators |
| 07/17/2008 | WO2007101264A3 Method for treating endothelial and epithelial cell disorders by administering high molecular weight peg-like compounds |
| 07/17/2008 | WO2007100895A3 Cancer treatment with gamma-secretase inhibitors |
| 07/17/2008 | WO2007100888A3 Antiviral drugs for treatment of arenavirus infection |
| 07/17/2008 | WO2007098010A3 Improved low molecular weight myc-max inhibitors |
| 07/17/2008 | WO2007092961A3 Antibacterial agents |
| 07/17/2008 | WO2007080149A9 Treatment of stressed patients |
| 07/17/2008 | WO2007075980A8 Lansoprazole orally disintegrating tablets |